Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changing biological behaviour of NETs during the evolution of the disease: progress on progression
Krystallenia Alexandraki, Ariadni Spyroglou, Stylianos Kykalos, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 5, pp. R121-R140
Open Access | Times Cited: 19

Showing 19 citing articles:

Gastritis, Gastric Polyps and Gastric Cancer
Helge L. Waldum, Reidar Fossmark
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6548-6548
Open Access | Times Cited: 104
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
Isabella Reccia, Madhava Pai, Kumar Jayant, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1861-1861
Open Access | Times Cited: 15
Retrospective analysis of criteria for oncological completion surgery of neuroendocrine tumors of the appendix
Sabine Wächter, Dimitrios Panidis, Moritz Jesinghaus, et al.
Langenbeck s Archives of Surgery (2025) Vol. 410, Iss. 1
Open Access
New Developments in Gastric Neuroendocrine Neoplasms
Klaire Exarchou, Nathan Stephens, Andrew R. Moore, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 1, pp. 77-88
Open Access | Times Cited: 14
Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?
Maria Passhak, Mairéad G. McNamara, Richard Hubner, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 5, pp. 101836-101836
Closed Access | Times Cited: 7
Emerging Precision Medicine Approaches for Lung Neuroendocrine Tumors
Claire K. Mulvey
Cancers (2023) Vol. 15, Iss. 23, pp. 5575-5575
Open Access | Times Cited: 5
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
Mark J C van Treijen, Catharina M. Korse, Wieke H.M. Verbeek, et al.
Endocrine Connections (2022) Vol. 11, Iss. 10
Open Access | Times Cited: 9
Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
Karolina Skubisz, Krzysztof Dąbkowski, Emilia Samborowska, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3242-3242
Open Access | Times Cited: 5
Modified Histopathological Grading Optimizes Prediction of Survival Outcomes in Small Intestinal Neuroendocrine Tumors
Kosmas Daskalakis, Marina Tsoli, Göran Wallin, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2222-e2230
Open Access | Times Cited: 1
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs
Jonathan M. Loree, David Chan, Jennifer Lim, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 1
Functioning and nonfunctioning pNENs
Kosmas Daskalakis
Current Opinion in Endocrine and Metabolic Research (2021) Vol. 18, pp. 284-290
Open Access | Times Cited: 8
“The past is a different country, they do things differently there”: using the SEER data-base to assess prognosis in neuroendocrine tumours
Krystallenia Alexandraki, Maria Chiara Zatelli, Ashley Grossman
Endocrine (2022) Vol. 75, Iss. 3, pp. 725-727
Closed Access | Times Cited: 6
Multimodal management of foregut neuroendocrine neoplasms
Yichan Zhou, James Weiquan Li, Noriya Uedo
Best Practice & Research Clinical Gastroenterology (2024) Vol. 68, pp. 101889-101889
Closed Access
Longitudinal Changes in Ki-67 Indices in Small-Intestinal Neuroendocrine Tumours and Their Impact on Survival
Kosmas Daskalakis, Marina Tsoli, Maria Wedin, et al.
Neuroendocrinology (2024), pp. 1-9
Open Access
Unraveling the Microbiome’s Role in Neuroendocrine Neoplasms: A New Perspective
Sara Massironi
Neuroendocrinology (2024) Vol. 114, Iss. 11, pp. 977-980
Closed Access
Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer
Helge L. Waldum
Cancers (2021) Vol. 13, Iss. 13, pp. 3159-3159
Open Access | Times Cited: 3
A well-differentiated neuroendocrine tumour of high grade
Seung Hyun Lee, Tu Vinh Luong
Diagnostic histopathology (2023) Vol. 29, Iss. 11, pp. 503-506
Closed Access
Optimizing surveillance strategies in gastroenteropancreatic neuroendocrine tumours
Mark Jean Cornel van Treijen
(2022)
Open Access
The Evolution of Pancreatic Islet Function in a Diabetic Patient after Pancreatic Neuroendocrine Neoplasm Surgery: A Case Report
Ligang Zhou, Song Wen, Junhong Pan, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 23, Iss. 7, pp. 984-991
Closed Access
Page 1

Scroll to top